Aditxt,® Inc. (NASDAQ: $ADTX)’s Wholly-Owned Subsidiary Pearsanta, Inc. Looks to Expand Customer Base, Payor Access, and Genetic Testing with a Non-Binding Letter of Intent to Acquire Natural State Laboratories and Natural State Genomics Aditxt, Inc. microcaps.com/biotechnology/…

"When you are in foreign country, it can be difficult to navigate the healthcare and insurance system of the country you are visiting or working in." Read how MedinAction has innovated to provide services for those in need. Via Forbes tinyurl.com/3fuzcfud #HealthCare

A ‘bionic pancreas’ that combines an insulin pump and automated dosing software has been approved by the US Food and Drugs Administration (FDA) for use by people living with #TypeOne diabetes in the US. tinyurl.com/yv7nuh2e #Innovation

Exciting news at Aditxt (NASDAQ: ADTX)! 🚀 We're thrilled to share that we’ve signed a definitive agreement to acquire Evofem Biosciences Biosciences, Inc., makers of Phexxi®—the only FDA-approved hormone-free contraceptive gel. Phexxi empowers women in a revolutionary way. This on-demand

Thanks to Maria Aspan from FORTUNE for speaking with Amro & Saundra from Evofem Biosciences about the recent announcement. We recognize Evofem's incredible potential, we're committed to ensuring its sustained success as a promising innovation, expanding accessibility to women

We've recently announced we have signed a Definitive Agreement to acquire Evofem Biosciences creators of Phexxi - the ONLY FDA-approved, non-hormonal contraceptive gel for women. If you haven’t seen their CEO’s TEDxSanDiego presentation, it’s a must-watch! Saundra's informative

"I've become more empathetic towards others, I've learnt patience is key. It's not easy. But I don't want to hide anymore and I don't want to feel like I have to cover up to fit society." Read Nikki's #psoriasis story here ow.ly/3bsP50QfTeO

We're driven to innovate for life-changing solutions. But it's stories like Kayla's, battling lung transplantation, that truly highlight our mission. Her journey is a poignant example of the lives we touch & the urgency of our work. That's our motivation every day. To make a

Aditxt subsidiary Pearsanta acquires MDNA's Mitomic™ Platform for $25M! Aiming at major strides in women's & men's health, and entering the booming liquid biopsy market. 🧬 Key Features: Precision diagnostics using mitochondrial DNA. Early, non-invasive disease detection.

Aditxt’s recently signed a definitive agreement to acquire Evofem Biosciences in a $100M transaction. We’re thrilled to re-share their news that Phexxi, a hormone-free contraceptive, is now available on Washington Medicaid plans without Prior Authorization. This change affects 1.8

Richmond life sciences company Aditxt Inc. is dipping into the M&A waters for the second time in a month. bizjournals.com/richmond/inno/…

Shocking data from UNFPA Almost half of all global pregnancies (121M annually) are unintended. Innovation is crucial in addressing this. Enter Evofem Biosciences Phexxi: Empowering women with reproductive health choices. We're committed to Phexxi's success, enhancing accessibility &

You don’t wear a car seat belt for protection when you’re not in a car…. Why daily birth control? Since 1960, that's been the norm, but every day isn't 'that day'. Meet Phexxi: The birth control revolution! Take charge only when needed - say goodbye to daily doses! Time for

Today is a day to celebrate Dr. Martin Luther King Jr. and his impact on civil rights and social justice. We also recognize that his actions and methods were a form of innovation within the social context of his time. His foresight in combining moral vision with strategic

Final Call to Join Our Investor Event Today! Amro Albanna will provide an overview of our plans for 2024 and the promising innovations showcasing our commitment to tackling complex health challenges. Don't miss this chance to be a part of our journey. Last chance to register

🌍 In South Sudan, girls are more likely to die in childbirth than finish school. 300K maternal deaths in 2020 DFID reports. Evofem Biosciences's Phexxi® leads in non-hormonal contraception, empowering women's reproductive health. lnkd.in/gvm543gD

Join Aditxt’s (NASDAQ:ADTX) Fireside Chat Friday, Feb 21 @ 11:30 AM ET CEO Amro Albanna will provide company update including key developments across Adimune, Pearsanta, and upcoming initiatives. Submit Qs by Feb 20 5PM ET: [email protected] us06web.zoom.us/webinar/regist…

.Aditxt, Inc. $ADTX Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk finance.yahoo.com/news/aditxt-su… #Cancer #investors

.@aditXt (Nasdaq: $ADTX), Inc. Regains Compliance with Nasdaq Listing Requirements #stockstowatch #stocksinnews #investor #daytrader finance.yahoo.com/news/aditxt-in…

.Aditxt, Inc. $ADTX Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 #StocksToWatch #stocksinnews #investors #smallcaps businesswire.com/news/home/2025…